| Product | Indication | Preclinical | Phase One | Phase Two | Phase Three | Commercial Rights |
| Retinal Disease Programs | ||||||
| KIO-301 (Intravitreal) | Retinitis Pigmentosa (Mutation Agnostic) |
|
|
|
|
Théa Open Innovation (global less Asia) |
| Choroideremia |
|
|
|
|
||
| Stargardt Disease |
|
|
|
|
||
| KIO-104 (Intravitreal) | Retinal Inflammation |
|
|
|
|
Kiora |
| Proliferative Vitreoretinopathy |
|
|||||